During a major phase III trial, pembrolizumab combined with standard treatment kept cancer at bay for an average of 60 months ...

A groundbreaking new urine test could soon help spot the early warning signs of lung cancer long before symptoms appear.

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events ...